Diaphragmatic and Rectus Femoris Muscles Ultrasonography in Relation to Motor and Respiratory Functions in Ambulatory Boys with Duchenne Muscular Dystrophy

 

 Artikel einzeln kaufen Lizenzen und Reprints

Abstract

Our aim was to establish correlations between GSGC (Gait, Stairs, Gower, Chair) scores and ultrasonographic (US) findings of rectus femoris muscle (RF) and to study correlation between pulmonary function tests (PFT) and diaphragmatic muscles thickness in ambulatory boys with Duchenne muscular dystrophy (DMD). Twenty-four ambulatory boys with DMD were included. Their motor functions were assessed using GSGC scale. All the participants underwent PFT. US was used to assess RF quantitatively (gray scale analysis) and semiquantitatively (modified Heckmatt score) besides assessment of diaphragmatic muscle thickness. Patients with grade IV modified Heckmatt scale had the worst functional performance compared with grade III and II evidenced by having the highest total GSGC score (p < 0.01), worst gait, stairs climbing, chair rising scores, and the longest time for rising from floor (p < 0.05). A significant positive correlation was detected between forced expiratory volume in 1s/ forced vital capacity and right diaphragmatic muscle thickness. GSGC score positively correlated with RF US findings (quantitative gray scale analysis). GSGC score is a successful tool that could be used for clinical evaluation of patients with DMD. Diaphragmatic US introduces an option for screening and monitoring of restrictive respiratory pattern in patients with DMD after determining the reference values of diaphragmatic muscle thickness in different ages.

Ethical Considerations

The study gained approval from the Faculty of Medicine, Ain Shams University Ethical Committee. Informed consents and assent when applicable were obtained from all the participating caregivers and patients, respectively.

Publikationsverlauf

Eingereicht: 19. Dezember 2022

Angenommen: 19. April 2023

Artikel online veröffentlicht:
12. Juni 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

• References

• 1 Emery AE. Population frequencies of inherited neuromuscular diseases--a world survey. Neuromuscul Disord 1991; 1 (01) 19-29
  CrossrefPubMedGoogle Scholar
• 2 Hoffman EP, Brown Jr RH, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987; 51 (06) 919-928
  CrossrefPubMedGoogle Scholar
• 3 Boland BJ, Silbert PL, Groover RV, Wollan PC, Silverstein MD. Skeletal, cardiac, and smooth muscle failure in Duchenne muscular dystrophy. Pediatr Neurol 1996; 14 (01) 7-12
  CrossrefPubMedGoogle Scholar
• 4 Bushby K, Finkel R, Birnkrant DJ. et al; DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 2010; 9 (01) 77-93
  CrossrefPubMedGoogle Scholar
• 5 Mayhew AG, Moat D, McDermott MP. et al; Muscle Study Group and TREAT-NMD. Functional outcome measures in young, steroid-naïve boys with Duchenne muscular dystrophy. Neuromuscul Disord 2022; 32 (06) 460-467
  CrossrefPubMedGoogle Scholar
• 6 Arora H. Commonly available outcome measures for use in Indian boys with Duchenne muscular dystrophy. Neurol India 2018; 66 (05) 1279-1285
  CrossrefPubMedGoogle Scholar
• 7 Hafner P, Phadke R, Manzur A. et al. Electromyography and muscle biopsy in paediatric neuromuscular disorders - evaluation of current practice and literature review. Neuromuscul Disord 2019; 29 (01) 14-20
  CrossrefPubMedGoogle Scholar
• 8 VanHorn TA, Cartwright MS. Neuromuscular ultrasound in the pediatric population. Diagnostics (Basel) 2020; 10 (12) x
  PubMedGoogle Scholar
• 9 Zaidman CM, Connolly AM, Malkus EC, Florence JM, Pestronk A. Quantitative ultrasound using backscatter analysis in Duchenne and Becker muscular dystrophy. Neuromuscul Disord 2010; 20 (12) 805-809
  CrossrefPubMedGoogle Scholar
• 10 Zaidman CM, Malkus EC, Connolly AM. Muscle ultrasound quantifies disease progression over time in infants and young boys with Duchenne muscular dystrophy. Muscle Nerve 2015; 52 (03) 334-338
  CrossrefPubMedGoogle Scholar
• 11 Bulut N, Karaduman A, Alemdaroğlu-Gürbüz İ, Yilmaz Ö, Topaloğlu H, Özçakar L. Ultrasonographic assessment of lower limb muscle architecture in children with early-stage Duchenne muscular dystrophy. Arq Neuropsiquiatr 2022; 80 (05) 475-481
  Artikel in Thieme ConnectPubMedGoogle Scholar
• 12 Abdulhady H, Sakr HM, Elsayed NS. et al. Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI. Acta Myol 2022; 41 (01) 1-14
  PubMedGoogle Scholar
• 13 Angelini C, Semplicini C, Ravaglia S. et al; Italian Group on GSDII. New motor outcome function measures in evaluation of late-onset Pompe disease before and after enzyme replacement therapy. Muscle Nerve 2012; 45 (06) 831-834
  CrossrefPubMedGoogle Scholar
• 14 Pillen S, van Keimpema M, Nievelstein RA, Verrips A, van Kruijsbergen-Raijmann W, Zwarts MJ. Skeletal muscle ultrasonography: visual versus quantitative evaluation. Ultrasound Med Biol 2006; 32 (09) 1315-1321
  CrossrefPubMedGoogle Scholar
• 15 Moreta MC, Fleet A, Reebye R. et al. Reliability and validity of the modified Heckmatt Scale in evaluating muscle changes with ultrasound in spasticity. Arch Rehabil Res Clin Transl 2020; 2 (04) 100071
  PubMedGoogle Scholar
• 16 Wang L, Xu M, Liu D, Liang Y, Feng P, Li H, Zhu Y, He R, Lin J, Zhang H, Liao Z, Zhang C. Serum creatinine as a biomarker for dystrophinopathy: a cross-sectional and longitudinal study. BMC Neurol 2021; Sep 25; 21 (01) 372
  CrossrefPubMedGoogle Scholar
• 17 Jansen M, van Alfen N, Nijhuis van der Sanden MW, van Dijk JP, Pillen S, de Groot IJ. Quantitative muscle ultrasound is a promising longitudinal follow-up tool in Duchenne muscular dystrophy. Research Support, Non-U.S. Gov't. Neuromuscular disorders: NMD . Apr 2012; 22 (04) 306-317
  CrossrefPubMedGoogle Scholar
• 18 Zambon AA, Ayyar Gupta V, Ridout D. et al. Peak functional ability and age at loss of ambulation in Duchenne muscular dystrophy. Developmental medicine and child neurology . Aug 2022; 64 (08) 979-988
  CrossrefPubMedGoogle Scholar
• 19 Montagnese F, Rastelli E, Khizanishvili N, Massa R, Stahl K, Schoser B. Validation of Motor Outcome Measures in Myotonic Dystrophy Type 2. Front Neurol 2020; Apr 21; 11: 306
  CrossrefPubMedGoogle Scholar
• 20 Laviola M, Priori R, D'Angelo MG, Aliverti A. Assessment of diaphragmatic thickness by ultrasonography in Duchenne muscular dystrophy (DMD) patients. Research Support, Non-U.S. Gov't. PloS one 2018; 13 (07) e0200582
  CrossrefPubMedGoogle Scholar
• 21 LoMauro A, Romei M, Gandossini S. , et al. Evolution of respiratory function in Duchenne muscular dystrophy from childhood to adulthood. The European respiratory journal. Feb 2018; 51(02):
  PubMedGoogle Scholar
• 22 Pennati F, Arrigoni F, LoMauro A. , et al. Diaphragm Involvement in Duchenne Muscular Dystrophy (DMD): An MRI Study. J Magn Reson Imaging 2020; 51 (02) 461-471
  CrossrefPubMedGoogle Scholar
• 23 Thibaud JL, Matot B, Barthelemy I, Fromes Y, Blot S, Carlier PG. Anatomical and mesoscopic characterization of the dystrophic diaphragm: An in vivo nuclear magnetic resonance imaging study in the Golden retriever muscular dystrophy dog. Neuromuscular disorders: NMD . Apr 2017; 27 (04) 315-325
  CrossrefPubMedGoogle Scholar
• 24 Gottesman E, McCool FD. Ultrasound evaluation of the paralyzed diaphragm. American journal of respiratory and critical care medicine . May 1997; 155 (05) 1570-1574
  CrossrefPubMedGoogle Scholar